Related Experiment Video
Updated: Aug 30, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Changes in hepatic parenchymal blood flow with colorectal metastases: increase in arterial and decrease in portal
Satoshi Kunishima1, Hiroki Taniguchi, Akihiro Yamaguchi
1Department of Surgery, Kyoto Kizugawa Hospital, Hirakawa, Jouyou City, Kyoto, 610-0101, Japan. ken_kunishima@mta.biglobe.ne.jp
Background/Aims:
We investigated the changes in arterial and portal blood flow in the non-tumorous liver parenchyma in the presence of colorectal hepatic metastases using the H(2)15O dynamic positron emission tomography method.
Methodology:
Thirty-eight patients were classified into colorectal hepatic metastases (MET), hemangioma (HEM), and no liver tumor (NR) groups. We quantitatively measured arterial blood flow and portal blood flow in each anatomical segment of the non-tumorous liver parenchyma.
Results:
In the MET, HEM and NR groups, the non-tumorous arterial blood flow was 39.89, 32.77 and 28.85 mL/100 g/minute. Each non-tumorous portal blood flow was 71.61, 100.39 and 94 mL/100 g/minute. We observed a significant difference in arterial blood flow between MET and NR (p = 0.0296), although there was no significant difference in total blood flow among three groups. In MET, we discovered a significant correlation between tumor and non-tumorous arterial blood flow in the liver parenchyma (r = 0.7120, p = 0.0209). Non-tumorous arterial blood flow and PBF were 39.07 and 62.74 mL/100 g/minute in the segment with metastases, and 41.95 and 66.23 mL/100 g/minute without metastases. There were no significant differences in any blood flow between those with and without metastasis.
Conclusions:
The presence of hepatic metastases increased arterial blood flow with a compensatory decrease in portal blood flow within the non-tumorous liver parenchyma, irrespective of the number, location and size of the metastatic lesions.
Related Concept Videos
Portal Hypertension
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cirrhosis II: Pathophysiology

